Philip Morris (PM) Up 5% Since Last Earnings Report: Can It Continue?

Philip Morris International (PM) reported Q2 2025 adjusted EPS of $1.91, surpassing consensus estimates by 20.1% year-over-year, though net revenues of $10.14 billion missed expectations. The earnings beat was primarily driven by positive pricing and robust smoke-free product volumes, notably IQOS and ZYN, which now constitute 41% of total revenues, partially offsetting declines in traditional cigarette volumes. Consequently, PM raised its full-year 2025 adjusted EPS outlook to $7.43-$7.56, projecting 13-15% growth, and anticipates 6-8% organic net revenue growth. Despite the positive quarterly performance and outlook revision, analyst estimates have shown a downward trend since the release, with the stock currently holding a Zacks Rank #3 (Hold).

Analysis

Philip Morris International reported a mixed second quarter, characterized by an earnings beat and a revenue miss. Adjusted EPS of $1.91 grew 20.1% year-over-year, surpassing consensus, while net revenues of $10.14 billion fell short of estimates despite a 6.8% organic increase. The results highlight the company's successful strategic pivot, as robust growth in its smoke-free product (SFP) portfolio is effectively compensating for declines in the legacy combustible business. SFP revenues surged 15.2% organically, now representing a significant 41% of the company's total revenues, driven by the strength of IQOS heated tobacco and ZYN oral nicotine pouches. In contrast, combustible product revenue grew a modest 2% organically, relying entirely on price increases to offset volume declines. Management expressed confidence by raising its full-year 2025 adjusted EPS guidance to a range of $7.43-$7.56, implying 13-15% growth. However, conflicting signals exist; the company carries significant long-term debt of $42.4 billion, has suspended share repurchases for 2025, and analyst estimates have been trending downward post-release, leading to a Zacks Rank #3 (Hold) despite the stock's recent 5% outperformance.

Key Decisions for Investors

• Investors should weigh the robust growth in the smoke-free products segment, which now constitutes 41% of revenue and underpins the raised full-year EPS guidance, as a core component of the long-term bull case.
• It is critical to monitor the company's highly leveraged balance sheet, a shareholder deficit of $10 billion, and the suspension of share repurchases for 2025, which are significant risk factors that could temper capital returns.
• Pay close attention to the divergence between the company's strong reported results and the downward trend in analyst estimates; a continuation of this trend could signal underlying concerns and precede a pullback in the stock.
• Given the stock's strong 'A' grade for Growth but weak 'D' grades for Value and Momentum, investors should assess if the growth trajectory in smoke-free products justifies a position despite the poor value and momentum metrics.